Search for Clinical Trial Results
Hyperlipoproteinemias - 25 Studies Found
Status | Study |
Completed |
Study Name: Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2013-03-10 Interventions:
|
Completed |
Study Name: The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2012-07-17 Interventions:
|
Recruiting |
Study Name: Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes Condition: Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia Date: 2016-05-26 |
Recruiting |
Study Name: Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Patients With Hyperlipoproteinemia(a) and Cardiovascular Disease Condition:
Date: 2017-01-31 Interventions:
|
Completed |
Study Name: Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins Condition:
Date: 1999-11-03 |
Withdrawn |
Study Name: Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a) Condition:
Date: 2010-02-08 Interventions: |
Completed |
Study Name: A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin Condition:
Date: 2010-01-26 Interventions:
|
Terminated |
Study Name: Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042) Condition:
|
Active, not recruiting |
Study Name: Study to Assess the Tolerability and Efficacy of Anacetrapib Co-administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) Condition:
|
Terminated |
Study Name: Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia Condition:
Date: 2010-11-12 Interventions: Drug: Niacin/ Laropiprant 1000/ 20 mg first 4 weeks, 2000/40 mg next 8 weeks; daily |